Katy L. Everett

851 total citations
17 papers, 638 citations indexed

About

Katy L. Everett is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Katy L. Everett has authored 17 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Oncology. Recurrent topics in Katy L. Everett's work include Protein Kinase Regulation and GTPase Signaling (6 papers), Receptor Mechanisms and Signaling (6 papers) and CAR-T cell therapy research (3 papers). Katy L. Everett is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (6 papers), Receptor Mechanisms and Signaling (6 papers) and CAR-T cell therapy research (3 papers). Katy L. Everett collaborates with scholars based in United Kingdom, Germany and United States. Katy L. Everett's co-authors include Dermot M.F. Cooper, Michelle L. Halls, Debbie Willoughby, Philipp Skroblin, Enno Klußmann, Matilda Katan, Jonathan Pacheco, Luis Vaca, Tom D. Bunney and Antonio Ciruela and has published in prestigious journals such as Journal of Biological Chemistry, Molecular Cell and PLoS ONE.

In The Last Decade

Katy L. Everett

16 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katy L. Everett United Kingdom 14 390 119 106 105 85 17 638
Bernardo Ortega United States 9 466 1.2× 49 0.4× 54 0.5× 74 0.7× 44 0.5× 13 728
Jacob Thastrup Denmark 11 626 1.6× 103 0.9× 40 0.4× 44 0.4× 35 0.4× 15 829
Masayuki Tobo Japan 20 940 2.4× 90 0.8× 158 1.5× 115 1.1× 36 0.4× 27 1.2k
Adam F. Odell United Kingdom 16 527 1.4× 118 1.0× 81 0.8× 48 0.5× 99 1.2× 29 830
Colin A. Syme United States 11 673 1.7× 235 2.0× 28 0.3× 87 0.8× 48 0.6× 11 842
Hristina Ivanova Belgium 13 560 1.4× 101 0.8× 64 0.6× 49 0.5× 54 0.6× 18 747
Carrie D. House United States 15 520 1.3× 99 0.8× 58 0.5× 30 0.3× 31 0.4× 30 766
Kunyan He China 15 335 0.9× 118 1.0× 88 0.8× 60 0.6× 12 0.1× 31 706
Sandrine Evellin Germany 9 752 1.9× 162 1.4× 39 0.4× 69 0.7× 17 0.2× 10 916
Koei Shinzawa Japan 14 360 0.9× 113 0.9× 37 0.3× 74 0.7× 22 0.3× 20 755

Countries citing papers authored by Katy L. Everett

Since Specialization
Citations

This map shows the geographic impact of Katy L. Everett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katy L. Everett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katy L. Everett more than expected).

Fields of papers citing papers by Katy L. Everett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katy L. Everett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katy L. Everett. The network helps show where Katy L. Everett may publish in the future.

Co-authorship network of co-authors of Katy L. Everett

This figure shows the co-authorship network connecting the top 25 collaborators of Katy L. Everett. A scholar is included among the top collaborators of Katy L. Everett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katy L. Everett. Katy L. Everett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Gaspar, Miguel, et al.. (2020). CD137/OX40 Bispecific Antibody Induces Potent Antitumor Activity that Is Dependent on Target Coengagement. Cancer Immunology Research. 8(6). 781–793. 43 indexed citations
2.
Everett, Katy L., et al.. (2018). Generation of Fcabs targeting human and murine LAG-3 as building blocks for novel bispecific antibody therapeutics. Methods. 154. 60–69. 22 indexed citations
3.
Kraman, Matthew, Katy L. Everett, Mustapha Faroudi, et al.. (2018). Abstract 2719: Dual blockade of PD-L1 and LAG-3 with FS118, a unique bispecific antibody, induces CD8+ T-cell activation and modulates the tumor microenvironment to promote antitumor immune responses. Cancer Research. 78(13_Supplement). 2719–2719. 13 indexed citations
4.
Everett, Katy L., et al.. (2017). Abstract PR06: A LAG-3/PD-L1 bispecific antibody inhibits tumour growth in two syngeneic colon carcinoma models. Cancer Immunology Research. 5(3_Supplement). PR06–PR06. 3 indexed citations
5.
Doody, Jacqueline, et al.. (2016). Abstract B091: A LAG-3/PD-L1 bispecific antibody inhibits tumor growth in two syngeneic colon carcinoma models. Cancer Immunology Research. 4(11_Supplement). B091–B091. 1 indexed citations
6.
Hodson, David J., Ryan K. Mitchell, Lorella Marselli, et al.. (2014). ADCY5 Couples Glucose to Insulin Secretion in Human Islets. Diabetes. 63(9). 3009–3021. 112 indexed citations
7.
Everett, Katy L. & Dermot M.F. Cooper. (2013). An Improved Targeted cAMP Sensor to Study the Regulation of Adenylyl Cyclase 8 by Ca2+ Entry through Voltage-Gated Channels. PLoS ONE. 8(9). e75942–e75942. 25 indexed citations
8.
Everett, Katy L. & Dermot M.F. Cooper. (2012). cAMP measurements with FRET-based sensors in excitable cells. Biochemical Society Transactions. 40(1). 179–183. 4 indexed citations
9.
Wachten, Sebastian, et al.. (2012). Muscarinic receptors stimulate AC2 by novel phosphorylation sites, whereas Gβγ subunits exert opposing effects depending on the G-protein source. Biochemical Journal. 447(3). 393–405. 14 indexed citations
10.
Willoughby, Debbie, Katy L. Everett, Michelle L. Halls, et al.. (2012). Direct Binding Between Orai1 and AC8 Mediates Dynamic Interplay Between Ca 2+ and cAMP Signaling. Science Signaling. 5(219). ra29–ra29. 115 indexed citations
11.
Willoughby, Debbie, Michelle L. Halls, Katy L. Everett, et al.. (2012). A key phosphorylation site in AC8 mediates regulation of Ca2+-dependent cAMP dynamics by an AC8–AKAP79–PKA signalling complex. Journal of Cell Science. 125(23). 5850–5859. 32 indexed citations
12.
Maclean, John, Darren Edwards, Katy L. Everett, et al.. (2011). Identification of potent, soluble, and orally active TRPV1 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(8). 2559–2563. 19 indexed citations
13.
Everett, Katy L., Tom D. Bunney, Anca Margineanu, et al.. (2011). Membrane Environment Exerts an Important Influence on Rac-Mediated Activation of Phospholipase Cγ2. Molecular and Cellular Biology. 31(6). 1240–1251. 22 indexed citations
14.
Willoughby, Debbie, Nanako Masada, Sebastian Wachten, et al.. (2010). AKAP79/150 Interacts with AC8 and Regulates Ca2+-dependent cAMP Synthesis in Pancreatic and Neuronal Systems. Journal of Biological Chemistry. 285(26). 20328–20342. 66 indexed citations
15.
Bunney, Tom D., S. Mark Roe, Petra Vatter, et al.. (2009). Structural Insights into Formation of an Active Signaling Complex between Rac and Phospholipase C Gamma 2. Molecular Cell. 34(2). 223–233. 54 indexed citations
16.
Everett, Katy L., Tom D. Bunney, Youngdae Yoon, et al.. (2009). Characterization of Phospholipase Cγ Enzymes with Gain-of-Function Mutations. Journal of Biological Chemistry. 284(34). 23083–23093. 43 indexed citations
17.
Walliser, Claudia, Richard Harris, Katy L. Everett, et al.. (2008). Rac Regulates Its Effector Phospholipase Cγ2 through Interaction with a Split Pleckstrin Homology Domain. Journal of Biological Chemistry. 283(44). 30351–30362. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026